they require a physicians prescription
These programs are often run by the drug manufacturer and can help lower the cost of the medication if you qualify based on your income
Acute Gallbladder Disease: Acute events of gallbladder disease such as cholelithiasis or cholecystitis have been reported in GLP-1 receptor agonist trials and postmarketing
Regulatory bodies approved GLP-1 receptor agonists for glycemic control include: Dulaglutide (subcutaneous-SC), exenatide injectable solution subcutaneous, exenatide injectable suspension SC, liraglutide SC, liraglutide/insulin degludec , lixisenatide/insulin glargine, semaglutide (oral, SC), tirzepatide (dual GIP/GLP-1 receptor agonist) and others
Benedetto J-P, Ortonne J-P, Voulot C, Khatchadourian C, Prota G, Thivolet J
While rare, Semaglutide can cause allergic reactions